Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q2 FY24 Earnings Presentation
23 slides from Amrutanjan Health Care's earnings presentation, Nov 14, 2023
Slide 1: Stock exchange covering letter for investor presentation
AHCL/SE/41/2023-24 November 14, 2023 The National Stock Exchange of India Limited BSE Limited | “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1* Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 | Symbol : AMRUTANJAN Scrip Code: 590006
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation - Quarter & Half Year Ended 30th September 2023 Date: 10th November 2023
Slide 3: Contents
Contents a. Business Update 1. Segment Performance 2. Activities 3. Operations b. Financials 1. Q2 Performance 2. H1 Performance c. Management Commentary Investor Presentation | Quarter and Half Year Ended 30th September 2023 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter and Half Year Ended 30th September 2023 3
Slide 5: Segment Performance
Segment Performance Head Category Body Category Congestion Category • The Head category in MAT Sept’23* is at 1637 • The Body category in MAT Sept’23* is valued at • Refreshed packaging designs across the crores. The value growth of 3.0% is ahead of 2845 crores with a value growth of 5.8% and a comp
Slide 6: Segment Performance
Segment Performance Period Care Category Beverages Category • Consistent brand investment (both ATL and BTL) resulted in the growth of Comfy • Fruitnik witnessed an growth of 44% in H1 Sanitary Napkins • Consistent investments on TV media has resulted in an increase of • Growth led by lead variant,
Slide 7: Segment Performance - New Products
Segment Performance - New Products Maha Strong (Glass Bottle) Relief Hot Drink Assorted Mint Pouch • To foster environmental protection for • Relief Cold and Cough hot drink launched to • Relief Cold and Cough drops in an assorted pack sustainable future, introduced Maha Strong in a address problem
Slide 8: Activities: Key Campaigns - TV Media
Activities: Key Campaigns - TV Media Head Body Congestion TV Media for each of the head balms TV Media for Body Range endorsed TV Media for Maha Strong TV Media for Congestion range. Also and head roll on by Olympic winner Mirabai Chanu showcasing the new Relief Hot Drink Period Care Electro+ TV Med
Slide 9: Activities: Key Campaigns - Digital
Activities: Key Campaigns - Digital Head 3 Balm campaign garnered 1.98 million Head category in Zambia received 48.8K likes reach. and 1.17K engagement through comments Body Congestion Back Pain Roll-On in Official Pain Relief Partner for Congestion range in Zambia got 9K likes Zambia got 8.5K likes
Slide 10: Activities: Key Campaigns - Digital
Activities: Key Campaigns - Digital Period Care Period Pain Roll-On received 67 lakhs views in YouTube and 827K views in Social Platforms Electro+ Electro+ on YouTube received Leading Influencers campaign for Electro+ garnered 525.5K+ views in Instagram 23.3 million views Investor Presentation | Qua
Slide 11: Activities: Sampling
Activities: Sampling Sampling – Head and Beverage Categories Sampling – Beverage • State: Maharashtra • States: Tamil Nadu, Karnataka, Telangana, Andhra Pradesh, Maharashtra, • Name of the activity: Pandharpur wari festival West Bengal, Delhi, Uttar Pradesh, Bihar and Odisha • Products: Head Roll On
Slide 12: Operations Update
Operations Update Coverage Closing Stock and Debtors • Increase in distribution points: Increased to 3782 in H1 (% increase till H1: • Closing stock reduced from 65 days to 50 days 6% over year ending March 23). This includes our entire network of • Debtors have reduced and stood at Rs 33.49 Crs in
Slide 13: Operations Update
Operations Update SAP Project: We have implemented the below during this period April to Sep’23 • Material Requirement Planning (MRP) • Automatic Payment run & Automatic RTGS collection posting by integrating the Bank portal with SAP. • Customer credit limits are fixed in SAP. Investor Presentation
Slide 14: Financials
Financials Investor Presentation | Quarter and Half Year Ended 30th September 2023 13
Slide 15: Financials – Q2 FY24
Financials – Q2 FY24 (Rs. in Crores) Net Sales Profit Before Tax Profit After Tax 110.72 12.77 99.31 17.42 9.21 6.85 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Investor Presentation | Quarter and Half Year Ended 30th September 2023 14
Slide 16: Financials – Q2 FY24
Financials – Q2 FY24 (Rs. in Crores) Net Sales - OTC Net Sales - Beverages 104.23 6.00 94.08 4.84 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Net Sales - Comfy Net Sales - Electro Plus 26.37 4.97 24.27 3.25 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Growth: 8.65% Investor Presentation | Quarter and Half Year Ended 30th Se
Slide 17: Financials – H1 FY24
Financials – H1 FY24 (Rs. in Crores) Net Sales Profit Before Tax Profit After Tax 177.17 181.67 22.67 16.43 18.64 13.86 H1 FY24 H1 FY23 H1 FY24 H1 FY23 H1 FY24 H1 FY23 Investor Presentation | Quarter and Half Year Ended 30th September 2023 16
Slide 18: Expenses – H1 FY24
Expenses – H1 FY24 (Rs. in Crores) Employee Benefit Expenses 23.18 24.42 H1 FY24 H1 FY23 Decrease: 5.08% Advertisement & Selling Expenses Other Expenses 25.57 24.88 23.59 23.49 H1 FY24 H1 FY23 H1 FY24 H1 FY23 Decrease: 7.74% Increase: 5.92% Investor Presentation | Quarter and Half Year Ended 30th Se
Slide 19: Financials – H1 FY24 – OTC Division
Financials – H1 FY24 – OTC Division (Rs. in Crores) Net Sales - OTC 160.23 166.65 Notes: • Majority of raw material prices are lower than H1 FY23. Menthol price is marginally higher than H1 FY23. H1 FY24 H1 FY23 • Majority of packing material prices are lower than H1 FY23. Net Sales - Comfy 46.97 41
Slide 20: Financials – H1 FY24 – Beverage Division
Financials – H1 FY24 – Beverage Division (Rs. in Crores) Net Sales - Beverages 16.13 13.97 Notes: • Majority of Raw Material prices are marginally higher when compared to H1 FY23. H1 FY24 H1 FY23 Growth: 15.46% • Major Packing Material prices are lower when compared to H1 FY23. Net Sales - Electro P
Slide 21: Management Commentary
Management Commentary Investor Presentation | Quarter and Half Year Ended 30th September 2023 20
Slide 22: Management Commentary
Management Commentary • We had to defer revenue of 9.7 crs to the next quarter owing to supply chain issues. • Our company has seen an excessive channel stock built up during the covid years that is being reduced. This is impeding top line growth in the recent quarters. We feel this phenomenon is te
Slide 23: Investor Presentation | Quarter and Half Year Ended 30th September 2023
Investor Presentation | Quarter and Half Year Ended 30th September 2023 22
Amrutanjan Health Care — Q2 FY24 Earnings Presentation on 6ix